Abbvie’s FDA recall record

Every recall the FDA has published for a product we list under Abbvie. A count on its own says little — a company making more products will record more recalls — so the events themselves are shown, most recent first.

1 recall on record1 Class III — unlikely to cause harm

PRED MILD20260518
Failed Stability Specifications

Reviews

No reviews yet. Be the first to write one.

Frequently asked questions

What does Abbvie make?

Abbvie makes prescription drugs, over-the-counter products. pharmaranks independently rates 50+ of its products — see the full list below.

How is Abbvie rated?

pharmaranks gives Abbvie a composite rating of 3.6 out of 5, based on FDA regulatory (recall-safety) data across its products. See the source breakdown on this page.

Where is Abbvie headquartered?

Abbvie is headquartered in United States.

When was Abbvie founded?

Abbvie was founded in 2012.

Where this rating comes from

Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.

FDA Drug Enforcement (recall) database — the recall history behind the safety score
DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
Drugs@FDA — approvals, strengths and marketing status

Products (50)

acular

acular ls

akineton

alphagan p

aminosol 5%

androderm

asacol hd

avycaz

bentyl preservative free

biaxin

biaxin xl

calcijex

canasa

carafate

choloxin

dalvance

decnupaz

delzicol

depacon

depakene

depakote

diasone sodium

durysta

emblaveo

emrelis

enablex

fetzima

fml forte

gelnique

gemonil

gengraf

harmonyl

humira

k-tab

kaletra

lastacaft

latisse

lexapro

lipidil

lumigan

mavik

mavyret

mivacron

mivacron in dextrose 5% in plastic container

nalbuphine hydrochloride

namenda

namenda xr

niaspan

niaspan titration starter pack

nimbex

Abbvie’s FDA recall record

Reviews

Write a review

Frequently asked questions

Where this rating comes from